Tigecycline Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global Tigecycline market size was valued at USD 1487.1 million in 2022 and is forecast to a readjusted size of USD 4498.2 million by 2029 with a CAGR of 17.1% during review period.

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.

Global Tigecycline Sales Channel is wide, like Hospital Pharmacies, Retail Pharmacies. Hospital Pharmacies is the largest consumer channel. Tigecycline can be mainly divided into Generic Drug, Original Drug. In 2019, North America dominated the global Tigecycline market, accounting for more than 34% of the total revenue.

This report is a detailed and comprehensive analysis for global Tigecycline market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Tigecycline market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Tigecycline market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tigecycline
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace

This report profiles key players in the global Tigecycline market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

   Pfizer (Wyeth)
   Sino Biopharmaceutical
   Zhejiang Hisun Pharma
   Jiangsu Hansoh Pharmaceutical
   Abbott
   Natco Pharma
   Lyka Labs Limited
   Fresenius Kabi
   Sandoz
   APOTEX
   Accord Healthcare
   Amneal Pharmaceuticals

   Original Drug
   Generic Drug

   Hospital Pharmacies
   Retail Pharmacies

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the Tigecycline market in 2025?

The Tigecycline market benefits from its broad-spectrum efficacy against multi-drug resistant bacterial infections, particularly in hospital settings. Its usage in treating complicated infections gives it a strong position in the global market. Additionally, ongoing studies to expand its indications may further drive demand.

What are the weaknesses of the Tigecycline market in 2025?

One weakness is its limited efficacy against certain pathogens, including Pseudomonas aeruginosa, which may hinder its widespread adoption. Its side effects, such as nausea and vomiting, also deter some healthcare providers from using it as a first-line treatment. Moreover, its high cost compared to alternatives may be a barrier.

What opportunities exist for the Tigecycline market in 2025?

The increasing prevalence of antibiotic-resistant infections globally presents a significant opportunity for Tigecycline. Expansion into new markets and the potential for improved formulations to enhance patient outcomes could drive market growth. Moreover, government initiatives to combat antibiotic resistance may further boost demand.

What threats could impact the Tigecycline market in 2025?

The emergence of new, more effective antibiotics could pose a threat, overshadowing Tigecycline’s market share. Additionally, regulatory hurdles and competition from generic versions of existing treatments may limit its growth. Rising concerns over the side effects may also reduce its preference among clinicians.

What political factors will affect the Tigecycline market in 2025?

Government policies and regulations related to antibiotic use and resistance are crucial for Tigecycline's market. Policies aimed at promoting the use of antibiotics in hospitals, alongside restrictions to prevent overuse, will play a major role. Additionally, government funding for research into new antibiotics could support Tigecycline's growth.

How will the economic environment impact the Tigecycline market in 2025?

The economic impact of rising healthcare costs may hinder the widespread adoption of Tigecycline due to its higher price compared to other antibiotics. However, as resistance to older antibiotics increases, the demand for more effective treatments like Tigecycline could rise, offsetting some of these economic challenges.

What social factors will influence the Tigecycline market in 2025?

Increasing awareness about antibiotic resistance and the need for effective treatments will drive demand for Tigecycline. However, patient concerns over side effects and longer hospital stays could limit its social acceptance. The role of healthcare professionals in recommending Tigecycline as a treatment will also play a key role.

What technological developments will impact the Tigecycline market in 2025?

Advancements in diagnostic technologies, such as rapid bacterial testing, may help identify infections susceptible to Tigecycline more quickly, driving its use. Additionally, new drug delivery methods or improved formulations that reduce side effects could increase its attractiveness in the market.

How will environmental factors affect the Tigecycline market in 2025?

Environmental concerns surrounding antibiotic resistance in the environment, such as in wastewater and soil, could lead to stricter regulations on antibiotic use. This may indirectly affect the Tigecycline market as manufacturers and healthcare providers will need to address sustainability concerns in drug disposal and usage.

What legal factors will impact the Tigecycline market in 2025?

Patent protections and intellectual property rights are important for maintaining market exclusivity for Tigecycline. Changes in patent laws or the introduction of generic versions could affect pricing and competition. Moreover, legal regulations on antibiotic resistance policies and prescription guidelines could influence its usage.

Who are the suppliers in the Tigecycline market in 2025?

The suppliers include pharmaceutical companies that manufacture Tigecycline, as well as raw material suppliers for its production. Additionally, suppliers of packaging materials, distribution networks, and those providing research and development services to improve the drug's formulation play an important role.

What are the inputs required in the Tigecycline market in 2025?

Inputs include the active pharmaceutical ingredient (API) used to produce Tigecycline, manufacturing equipment, packaging materials, research data, regulatory approvals, and healthcare professionals' expertise in recommending the drug. Market insights and distribution strategies are also essential for driving its reach.

What is the process involved in delivering Tigecycline to the market in 2025?

The process involves research and development of Tigecycline, clinical trials for efficacy and safety, obtaining regulatory approvals from health authorities, manufacturing, packaging, and distribution to healthcare facilities. The drug is then prescribed by healthcare providers to patients in need of treatment.

Who are the customers of the Tigecycline market in 2025?

Customers include hospitals, healthcare providers, clinics, and pharmaceutical distributors who purchase Tigecycline for the treatment of multi-drug resistant infections. Additionally, pharmaceutical wholesalers and government health agencies are key buyers in both private and public healthcare sectors.

What are the expected outcomes from the Tigecycline market in 2025?

The expected outcomes are effective treatment of complex bacterial infections, improved patient outcomes, and reduced mortality rates from infections that are resistant to other antibiotics. The market may also see greater healthcare provider confidence in Tigecycline, driven by evidence of its efficacy against resistant pathogens.

How does the threat of new entrants impact the Tigecycline market in 2025?

The threat of new entrants is moderate, as the market is heavily regulated, and significant investments are needed in research, development, and regulatory approvals. However, the increasing demand for antibiotics to combat drug-resistant infections may encourage new players to enter the market, although the high barriers to entry reduce this risk.

How intense is the rivalry among existing competitors in the Tigecycline market in 2025?

Rivalry is moderate to high due to the presence of established pharmaceutical companies and the increasing competition from alternative antibiotics and generics. The need to continuously improve formulations and reduce side effects fuels the competitive landscape, but Tigecycline’s niche in multi-drug resistant infections help differentiate it.

What is the bargaining power of suppliers in the Tigecycline market in 2025?

The bargaining power of suppliers is moderate. Although there are a few suppliers of the active pharmaceutical ingredients required to produce Tigecycline, the market for these raw materials is relatively stable. However, if key suppliers increase their prices or have limited capacity, it could impact production costs.

What is the bargaining power of buyers in the Tigecycline market in 2025?

The bargaining power of buyers is moderate. While hospitals and healthcare providers have some leverage due to bulk purchasing, Tigecycline’s effectiveness in treating resistant infections gives it significant value. However, alternative antibiotics or generics may reduce buyers’ willingness to pay a premium for Tigecycline.

How strong is the threat of substitute products in the Tigecycline market in 2025?

The threat of substitutes is moderate. Although other antibiotics may treat similar infections, Tigecycline’s broad-spectrum efficacy against multi-drug-resistant bacteria gives it an edge. However, the emergence of newer antibiotics and generics could eventually challenge its position in the market.

What are the key raw materials required for the Tigecycline market in 2025?

The key raw materials include the active pharmaceutical ingredient (API) used to synthesize Tigecycline, as well as excipients and chemicals necessary for the formulation and manufacturing process. These materials need to meet strict regulatory standards for purity and quality to ensure the drug’s effectiveness.

How will the supply chain for Tigecycline be impacted in 2025?

The supply chain could face challenges from disruptions in the availability of raw materials or delays in production due to global events, such as pandemics or political instability. Furthermore, the need for regulatory approvals at every stage of production could also slow down the supply chain and lead to delays in reaching markets.

What role do manufacturers play in the Tigecycline market in 2025?

Manufacturers play a critical role in ensuring the consistent production of Tigecycline to meet market demand. This involves securing high-quality raw materials, maintaining manufacturing facilities that meet stringent regulatory requirements, and adhering to Good Manufacturing Practices (GMP) to ensure drug safety and efficacy.

How does regulation affect the upstream dynamics of the Tigecycline market in 2025?

Regulation significantly impacts the upstream dynamics by requiring manufacturers to comply with stringent guidelines for the production of pharmaceuticals. These regulations ensure the safety and efficacy of the drug but may increase production costs and time to market, as regulatory approvals are time-consuming and costly.

What technological factors influence upstream activities in the Tigecycline market in 2025?

Advancements in drug manufacturing technologies, such as more efficient synthesis methods or improved quality control systems, can influence the upstream process by reducing production costs and increasing yield. Additionally, innovations in raw material sourcing and supply chain management can streamline operations and ensure consistent drug availability.

What are the key distribution channels for Tigecycline in 2025?

The key distribution channels for Tigecycline include pharmaceutical wholesalers, hospitals, clinics, and healthcare providers. Additionally, partnerships with government health programs and online platforms for pharmaceutical distribution may play a role in ensuring access to the drug across various regions.

How does the regulatory landscape affect midstream activities for Tigecycline in 2025?

Regulatory compliance plays a significant role in midstream activities, as Tigecycline must meet local, national, and international regulatory requirements before distribution. The approval process, along with adherence to storage, labeling, and shipping standards, ensures the drug’s safety and quality throughout its journey to healthcare facilities.

What role do logistics and supply chain management play in the Tigecycline market in 2025?

Logistics and supply chain management are crucial for maintaining the timely delivery of Tigecycline to healthcare providers. Efficient inventory management, transportation, and proper storage are key to ensuring that the drug remains effective and available for patients when needed, while also preventing disruptions in the supply chain.

How does competition among distributors influence the Tigecycline market in 2025?

Competition among distributors can impact pricing and availability. While multiple distributors may lead to more competitive pricing, ensuring that Tigecycline reaches its end users effectively is important. Distributors offering faster delivery times or more widespread networks may gain a competitive edge in the market.

What challenges exist in the midstream segment of the Tigecycline market in 2025?

Challenges include potential supply chain disruptions due to geopolitical factors, logistical inefficiencies, and fluctuating demand. Additionally, maintaining the cold chain and ensuring compliance with strict regulatory guidelines during transport can be complex and resource-intensive, potentially causing delays or increasing costs.

What are the key customers in the downstream segment of the Tigecycline market in 2025?

Key customers include hospitals, healthcare providers, emergency care units, and clinics that treat patients with multi-drug resistant infections. Additionally, government health programs and private pharmacies are important customers in both developed and emerging markets.

How do healthcare providers influence the demand for Tigecycline in 2025?

Healthcare providers, especially specialists in infectious diseases, play a pivotal role in prescribing Tigecycline for treating resistant infections. Their understanding of the drug’s efficacy, side effects, and clinical guidelines directly influences the demand and adoption of Tigecycline in treatment protocols.

How does pricing affect the downstream segment of the Tigecycline market in 2025?

Pricing is a critical factor for Tigecycline, especially as it competes with other antibiotics. Higher prices can limit its accessibility in cost-sensitive regions, particularly in public healthcare systems. However, the effectiveness of Tigecycline in treating resistant infections can justify its premium cost for hospitals and specialized care centers.

What are the challenges in the downstream distribution of Tigecycline in 2025?

Challenges include ensuring timely availability in healthcare settings, managing inventory levels, and maintaining proper storage conditions, particularly in regions with weaker infrastructure. Additionally, competition from alternative therapies and the rising preference for generics may affect the demand for Tigecycline.

How does patient awareness impact the downstream market for Tigecycline in 2025?

Patient awareness plays a smaller role compared to healthcare providers, but it can influence treatment adherence. As patients become more informed about antibiotic resistance and available treatment options, there may be increased demand for effective therapies like Tigecycline, especially in settings where resistant infections are prevalent.

Chapter 1, to describe Tigecycline product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tigecycline, with price, sales, revenue and global market share of Tigecycline from 2018 to 2023.
Chapter 3, the Tigecycline competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tigecycline breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tigecycline market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tigecycline.
Chapter 14 and 15, to describe Tigecycline sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of Tigecycline
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global Tigecycline Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Original Drug
       1.3.3 Generic Drug
   1.4 Market Analysis by Application
       1.4.1 Overview: Global Tigecycline Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Hospital Pharmacies
       1.4.3 Retail Pharmacies
   1.5 Global Tigecycline Market Size & Forecast
       1.5.1 Global Tigecycline Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global Tigecycline Sales Quantity (2018-2029)
       1.5.3 Global Tigecycline Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 Pfizer (Wyeth)
       2.1.1 Pfizer (Wyeth) Details
       2.1.2 Pfizer (Wyeth) Major Business
       2.1.3 Pfizer (Wyeth) Tigecycline Product and Services
       2.1.4 Pfizer (Wyeth) Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 Pfizer (Wyeth) Recent Developments/Updates
   2.2 Sino Biopharmaceutical
       2.2.1 Sino Biopharmaceutical Details
       2.2.2 Sino Biopharmaceutical Major Business
       2.2.3 Sino Biopharmaceutical Tigecycline Product and Services
       2.2.4 Sino Biopharmaceutical Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Sino Biopharmaceutical Recent Developments/Updates
   2.3 Zhejiang Hisun Pharma
       2.3.1 Zhejiang Hisun Pharma Details
       2.3.2 Zhejiang Hisun Pharma Major Business
       2.3.3 Zhejiang Hisun Pharma Tigecycline Product and Services
       2.3.4 Zhejiang Hisun Pharma Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Zhejiang Hisun Pharma Recent Developments/Updates
   2.4 Jiangsu Hansoh Pharmaceutical
       2.4.1 Jiangsu Hansoh Pharmaceutical Details
       2.4.2 Jiangsu Hansoh Pharmaceutical Major Business
       2.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Product and Services
       2.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
   2.5 Abbott
       2.5.1 Abbott Details
       2.5.2 Abbott Major Business
       2.5.3 Abbott Tigecycline Product and Services
       2.5.4 Abbott Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 Abbott Recent Developments/Updates
   2.6 Natco Pharma
       2.6.1 Natco Pharma Details
       2.6.2 Natco Pharma Major Business
       2.6.3 Natco Pharma Tigecycline Product and Services
       2.6.4 Natco Pharma Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 Natco Pharma Recent Developments/Updates
   2.7 Lyka Labs Limited
       2.7.1 Lyka Labs Limited Details
       2.7.2 Lyka Labs Limited Major Business
       2.7.3 Lyka Labs Limited Tigecycline Product and Services
       2.7.4 Lyka Labs Limited Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Lyka Labs Limited Recent Developments/Updates
   2.8 Fresenius Kabi
       2.8.1 Fresenius Kabi Details
       2.8.2 Fresenius Kabi Major Business
       2.8.3 Fresenius Kabi Tigecycline Product and Services
       2.8.4 Fresenius Kabi Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Fresenius Kabi Recent Developments/Updates
   2.9 Sandoz
       2.9.1 Sandoz Details
       2.9.2 Sandoz Major Business
       2.9.3 Sandoz Tigecycline Product and Services
       2.9.4 Sandoz Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Sandoz Recent Developments/Updates
   2.10 APOTEX
       2.10.1 APOTEX Details
       2.10.2 APOTEX Major Business
       2.10.3 APOTEX Tigecycline Product and Services
       2.10.4 APOTEX Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 APOTEX Recent Developments/Updates
   2.11 Accord Healthcare
       2.11.1 Accord Healthcare Details
       2.11.2 Accord Healthcare Major Business
       2.11.3 Accord Healthcare Tigecycline Product and Services
       2.11.4 Accord Healthcare Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Accord Healthcare Recent Developments/Updates
   2.12 Amneal Pharmaceuticals
       2.12.1 Amneal Pharmaceuticals Details
       2.12.2 Amneal Pharmaceuticals Major Business
       2.12.3 Amneal Pharmaceuticals Tigecycline Product and Services
       2.12.4 Amneal Pharmaceuticals Tigecycline Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Amneal Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Tigecycline by Manufacturer

   3.1 Global Tigecycline Sales Quantity by Manufacturer (2018-2023)
   3.2 Global Tigecycline Revenue by Manufacturer (2018-2023)
   3.3 Global Tigecycline Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of Tigecycline by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 Tigecycline Manufacturer Market Share in 2022
       3.4.2 Top 6 Tigecycline Manufacturer Market Share in 2022
   3.5 Tigecycline Market: Overall Company Footprint Analysis
       3.5.1 Tigecycline Market: Region Footprint
       3.5.2 Tigecycline Market: Company Product Type Footprint
       3.5.3 Tigecycline Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global Tigecycline Market Size by Region
       4.1.1 Global Tigecycline Sales Quantity by Region (2018-2029)
       4.1.2 Global Tigecycline Consumption Value by Region (2018-2029)
       4.1.3 Global Tigecycline Average Price by Region (2018-2029)
   4.2 North America Tigecycline Consumption Value (2018-2029)
   4.3 Europe Tigecycline Consumption Value (2018-2029)
   4.4 Asia-Pacific Tigecycline Consumption Value (2018-2029)
   4.5 South America Tigecycline Consumption Value (2018-2029)
   4.6 Middle East and Africa Tigecycline Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global Tigecycline Sales Quantity by Type (2018-2029)
   5.2 Global Tigecycline Consumption Value by Type (2018-2029)
   5.3 Global Tigecycline Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global Tigecycline Sales Quantity by Application (2018-2029)
   6.2 Global Tigecycline Consumption Value by Application (2018-2029)
   6.3 Global Tigecycline Average Price by Application (2018-2029)

7 North America

   7.1 North America Tigecycline Sales Quantity by Type (2018-2029)
   7.2 North America Tigecycline Sales Quantity by Application (2018-2029)
   7.3 North America Tigecycline Market Size by Country
       7.3.1 North America Tigecycline Sales Quantity by Country (2018-2029)
       7.3.2 North America Tigecycline Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe Tigecycline Sales Quantity by Type (2018-2029)
   8.2 Europe Tigecycline Sales Quantity by Application (2018-2029)
   8.3 Europe Tigecycline Market Size by Country
       8.3.1 Europe Tigecycline Sales Quantity by Country (2018-2029)
       8.3.2 Europe Tigecycline Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific Tigecycline Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific Tigecycline Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific Tigecycline Market Size by Region
       9.3.1 Asia-Pacific Tigecycline Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific Tigecycline Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America Tigecycline Sales Quantity by Type (2018-2029)
   10.2 South America Tigecycline Sales Quantity by Application (2018-2029)
   10.3 South America Tigecycline Market Size by Country
       10.3.1 South America Tigecycline Sales Quantity by Country (2018-2029)
       10.3.2 South America Tigecycline Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa Tigecycline Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa Tigecycline Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa Tigecycline Market Size by Country
       11.3.1 Middle East & Africa Tigecycline Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa Tigecycline Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 Tigecycline Market Drivers
   12.2 Tigecycline Market Restraints
   12.3 Tigecycline Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry
   12.5 Influence of COVID-19 and Russia-Ukraine War
       12.5.1 Influence of COVID-19
       12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

   13.1 Raw Material of Tigecycline and Key Manufacturers
   13.2 Manufacturing Costs Percentage of Tigecycline
   13.3 Tigecycline Production Process
   13.4 Tigecycline Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 Tigecycline Typical Distributors
   14.3 Tigecycline Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global Tigecycline Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global Tigecycline Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. Pfizer (Wyeth) Basic Information, Manufacturing Base and Competitors
   Table 4. Pfizer (Wyeth) Major Business
   Table 5. Pfizer (Wyeth) Tigecycline Product and Services
   Table 6. Pfizer (Wyeth) Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. Pfizer (Wyeth) Recent Developments/Updates
   Table 8. Sino Biopharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 9. Sino Biopharmaceutical Major Business
   Table 10. Sino Biopharmaceutical Tigecycline Product and Services
   Table 11. Sino Biopharmaceutical Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Sino Biopharmaceutical Recent Developments/Updates
   Table 13. Zhejiang Hisun Pharma Basic Information, Manufacturing Base and Competitors
   Table 14. Zhejiang Hisun Pharma Major Business
   Table 15. Zhejiang Hisun Pharma Tigecycline Product and Services
   Table 16. Zhejiang Hisun Pharma Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Zhejiang Hisun Pharma Recent Developments/Updates
   Table 18. Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base and Competitors
   Table 19. Jiangsu Hansoh Pharmaceutical Major Business
   Table 20. Jiangsu Hansoh Pharmaceutical Tigecycline Product and Services
   Table 21. Jiangsu Hansoh Pharmaceutical Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. Jiangsu Hansoh Pharmaceutical Recent Developments/Updates
   Table 23. Abbott Basic Information, Manufacturing Base and Competitors
   Table 24. Abbott Major Business
   Table 25. Abbott Tigecycline Product and Services
   Table 26. Abbott Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. Abbott Recent Developments/Updates
   Table 28. Natco Pharma Basic Information, Manufacturing Base and Competitors
   Table 29. Natco Pharma Major Business
   Table 30. Natco Pharma Tigecycline Product and Services
   Table 31. Natco Pharma Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. Natco Pharma Recent Developments/Updates
   Table 33. Lyka Labs Limited Basic Information, Manufacturing Base and Competitors
   Table 34. Lyka Labs Limited Major Business
   Table 35. Lyka Labs Limited Tigecycline Product and Services
   Table 36. Lyka Labs Limited Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Lyka Labs Limited Recent Developments/Updates
   Table 38. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
   Table 39. Fresenius Kabi Major Business
   Table 40. Fresenius Kabi Tigecycline Product and Services
   Table 41. Fresenius Kabi Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Fresenius Kabi Recent Developments/Updates
   Table 43. Sandoz Basic Information, Manufacturing Base and Competitors
   Table 44. Sandoz Major Business
   Table 45. Sandoz Tigecycline Product and Services
   Table 46. Sandoz Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Sandoz Recent Developments/Updates
   Table 48. APOTEX Basic Information, Manufacturing Base and Competitors
   Table 49. APOTEX Major Business
   Table 50. APOTEX Tigecycline Product and Services
   Table 51. APOTEX Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. APOTEX Recent Developments/Updates
   Table 53. Accord Healthcare Basic Information, Manufacturing Base and Competitors
   Table 54. Accord Healthcare Major Business
   Table 55. Accord Healthcare Tigecycline Product and Services
   Table 56. Accord Healthcare Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Accord Healthcare Recent Developments/Updates
   Table 58. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
   Table 59. Amneal Pharmaceuticals Major Business
   Table 60. Amneal Pharmaceuticals Tigecycline Product and Services
   Table 61. Amneal Pharmaceuticals Tigecycline Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Amneal Pharmaceuticals Recent Developments/Updates
   Table 63. Global Tigecycline Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 64. Global Tigecycline Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 65. Global Tigecycline Average Price by Manufacturer (2018-2023) & (USD/Unit)
   Table 66. Market Position of Manufacturers in Tigecycline, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 67. Head Office and Tigecycline Production Site of Key Manufacturer
   Table 68. Tigecycline Market: Company Product Type Footprint
   Table 69. Tigecycline Market: Company Product Application Footprint
   Table 70. Tigecycline New Market Entrants and Barriers to Market Entry
   Table 71. Tigecycline Mergers, Acquisition, Agreements, and Collaborations
   Table 72. Global Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
   Table 73. Global Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
   Table 74. Global Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
   Table 75. Global Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
   Table 76. Global Tigecycline Average Price by Region (2018-2023) & (USD/Unit)
   Table 77. Global Tigecycline Average Price by Region (2024-2029) & (USD/Unit)
   Table 78. Global Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 79. Global Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 80. Global Tigecycline Consumption Value by Type (2018-2023) & (USD Million)
   Table 81. Global Tigecycline Consumption Value by Type (2024-2029) & (USD Million)
   Table 82. Global Tigecycline Average Price by Type (2018-2023) & (USD/Unit)
   Table 83. Global Tigecycline Average Price by Type (2024-2029) & (USD/Unit)
   Table 84. Global Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 85. Global Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 86. Global Tigecycline Consumption Value by Application (2018-2023) & (USD Million)
   Table 87. Global Tigecycline Consumption Value by Application (2024-2029) & (USD Million)
   Table 88. Global Tigecycline Average Price by Application (2018-2023) & (USD/Unit)
   Table 89. Global Tigecycline Average Price by Application (2024-2029) & (USD/Unit)
   Table 90. North America Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 91. North America Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 92. North America Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 93. North America Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 94. North America Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
   Table 95. North America Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
   Table 96. North America Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
   Table 97. North America Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
   Table 98. Europe Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 99. Europe Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 100. Europe Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 101. Europe Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 102. Europe Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
   Table 103. Europe Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
   Table 104. Europe Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
   Table 105. Europe Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
   Table 106. Asia-Pacific Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 107. Asia-Pacific Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 108. Asia-Pacific Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 109. Asia-Pacific Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 110. Asia-Pacific Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
   Table 111. Asia-Pacific Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
   Table 112. Asia-Pacific Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
   Table 113. Asia-Pacific Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
   Table 114. South America Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 115. South America Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 116. South America Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 117. South America Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 118. South America Tigecycline Sales Quantity by Country (2018-2023) & (K Units)
   Table 119. South America Tigecycline Sales Quantity by Country (2024-2029) & (K Units)
   Table 120. South America Tigecycline Consumption Value by Country (2018-2023) & (USD Million)
   Table 121. South America Tigecycline Consumption Value by Country (2024-2029) & (USD Million)
   Table 122. Middle East & Africa Tigecycline Sales Quantity by Type (2018-2023) & (K Units)
   Table 123. Middle East & Africa Tigecycline Sales Quantity by Type (2024-2029) & (K Units)
   Table 124. Middle East & Africa Tigecycline Sales Quantity by Application (2018-2023) & (K Units)
   Table 125. Middle East & Africa Tigecycline Sales Quantity by Application (2024-2029) & (K Units)
   Table 126. Middle East & Africa Tigecycline Sales Quantity by Region (2018-2023) & (K Units)
   Table 127. Middle East & Africa Tigecycline Sales Quantity by Region (2024-2029) & (K Units)
   Table 128. Middle East & Africa Tigecycline Consumption Value by Region (2018-2023) & (USD Million)
   Table 129. Middle East & Africa Tigecycline Consumption Value by Region (2024-2029) & (USD Million)
   Table 130. Tigecycline Raw Material
   Table 131. Key Manufacturers of Tigecycline Raw Materials
   Table 132. Tigecycline Typical Distributors
   Table 133. Tigecycline Typical Customers

List of Figures

   Figure 1. Tigecycline Picture
   Figure 2. Global Tigecycline Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global Tigecycline Consumption Value Market Share by Type in 2022
   Figure 4. Original Drug Examples
   Figure 5. Generic Drug Examples
   Figure 6. Global Tigecycline Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global Tigecycline Consumption Value Market Share by Application in 2022
   Figure 8. Hospital Pharmacies Examples
   Figure 9. Retail Pharmacies Examples
   Figure 10. Global Tigecycline Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 11. Global Tigecycline Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 12. Global Tigecycline Sales Quantity (2018-2029) & (K Units)
   Figure 13. Global Tigecycline Average Price (2018-2029) & (USD/Unit)
   Figure 14. Global Tigecycline Sales Quantity Market Share by Manufacturer in 2022
   Figure 15. Global Tigecycline Consumption Value Market Share by Manufacturer in 2022
   Figure 16. Producer Shipments of Tigecycline by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 17. Top 3 Tigecycline Manufacturer (Consumption Value) Market Share in 2022
   Figure 18. Top 6 Tigecycline Manufacturer (Consumption Value) Market Share in 2022
   Figure 19. Global Tigecycline Sales Quantity Market Share by Region (2018-2029)
   Figure 20. Global Tigecycline Consumption Value Market Share by Region (2018-2029)
   Figure 21. North America Tigecycline Consumption Value (2018-2029) & (USD Million)
   Figure 22. Europe Tigecycline Consumption Value (2018-2029) & (USD Million)
   Figure 23. Asia-Pacific Tigecycline Consumption Value (2018-2029) & (USD Million)
   Figure 24. South America Tigecycline Consumption Value (2018-2029) & (USD Million)
   Figure 25. Middle East & Africa Tigecycline Consumption Value (2018-2029) & (USD Million)
   Figure 26. Global Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 27. Global Tigecycline Consumption Value Market Share by Type (2018-2029)
   Figure 28. Global Tigecycline Average Price by Type (2018-2029) & (USD/Unit)
   Figure 29. Global Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 30. Global Tigecycline Consumption Value Market Share by Application (2018-2029)
   Figure 31. Global Tigecycline Average Price by Application (2018-2029) & (USD/Unit)
   Figure 32. North America Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 33. North America Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 34. North America Tigecycline Sales Quantity Market Share by Country (2018-2029)
   Figure 35. North America Tigecycline Consumption Value Market Share by Country (2018-2029)
   Figure 36. United States Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 37. Canada Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 38. Mexico Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Europe Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 40. Europe Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 41. Europe Tigecycline Sales Quantity Market Share by Country (2018-2029)
   Figure 42. Europe Tigecycline Consumption Value Market Share by Country (2018-2029)
   Figure 43. Germany Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 44. France Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 45. United Kingdom Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. Russia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. Italy Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Asia-Pacific Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 49. Asia-Pacific Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 50. Asia-Pacific Tigecycline Sales Quantity Market Share by Region (2018-2029)
   Figure 51. Asia-Pacific Tigecycline Consumption Value Market Share by Region (2018-2029)
   Figure 52. China Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 53. Japan Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 54. Korea Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. India Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Southeast Asia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. Australia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. South America Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 59. South America Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 60. South America Tigecycline Sales Quantity Market Share by Country (2018-2029)
   Figure 61. South America Tigecycline Consumption Value Market Share by Country (2018-2029)
   Figure 62. Brazil Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 63. Argentina Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 64. Middle East & Africa Tigecycline Sales Quantity Market Share by Type (2018-2029)
   Figure 65. Middle East & Africa Tigecycline Sales Quantity Market Share by Application (2018-2029)
   Figure 66. Middle East & Africa Tigecycline Sales Quantity Market Share by Region (2018-2029)
   Figure 67. Middle East & Africa Tigecycline Consumption Value Market Share by Region (2018-2029)
   Figure 68. Turkey Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 69. Egypt Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 70. Saudi Arabia Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. South Africa Tigecycline Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Tigecycline Market Drivers
   Figure 73. Tigecycline Market Restraints
   Figure 74. Tigecycline Market Trends
   Figure 75. Porters Five Forces Analysis
   Figure 76. Manufacturing Cost Structure Analysis of Tigecycline in 2022
   Figure 77. Manufacturing Process Analysis of Tigecycline
   Figure 78. Tigecycline Industrial Chain
   Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 80. Direct Channel Pros & Cons
   Figure 81. Indirect Channel Pros & Cons
   Figure 82. Methodology
   Figure 83. Research Process and Data Source